Endothelin-1 receptor antagonist: Effects on endothelin- and cyclosporine-treated mesangial cells

63Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Endothelin-1 (Et) has profound effects on glomerular microcirculation and mesangial cell contraction. A parameter of mesangial cell contraction was examined by measuring myosin light chain phosphorylation (MLCP) in glomerular mesangial cells in the presence and absence of a newly developed endothelin-1 receptor antagonist (EtA). Addition of Et alone (10 nM) caused a marked increase in MLCP, which, on average, rose by 53 ± 6% above the level in cells exposed to vehicle (P < 0.0005). This effect was shown to continue for at least one hour; MLCP at 60 minutes was 64 ± 12% higher than controls, (P < 0.025), constituting a unique observation of an in vitro parameter which parallels the characteristic in vivo effect of Et. Treatment of cells with EtA virtually abolished this Et-induced increase in MLCP, which rose by only 2 ± 3% and - 1 ± 4% for doses of EtA of 44 nM and 66 nM, respectively. Examination of the intracellular calcium concentration, [Ca2+]i, revealed that EtA almost completely abolished the transient increase in [Ca2+]i evoked by Et and also suppressed the early portions of the sustained increase in [Ca2+]i. EtA was ineffective in abolishing [Ca2+]i increase in response to arginine vasopressin. Finally, to evaluate EtA's efficacy in a pathophysiologic setting, we also studied mesangial cells exposed to cyclosporine (Cs). Exposure of mesangial cells to Cs (10-5 M) for 60 minutes caused a significant increase in MLCP, on average, by 38 ± 6% above control (P < 0.0005), while cells exposed to Cs in the presence of EtA increased MLCP significantly less, by only 15 ± 9%. These data provide further evidence for Et's long-lasting cellular actions, and demonstrate inhibitory effects of an Et receptor antagonist after direct cellular exposure to Et and also after Cs exposure, a pathophysiologic setting which likely involves Et.

Cite

CITATION STYLE

APA

Takeda, M., Breyer, M. D., Noland, T. D., Homma, T., Hoover, R. L., Inagami, T., & Kon, V. (1992). Endothelin-1 receptor antagonist: Effects on endothelin- and cyclosporine-treated mesangial cells. Kidney International, 41(6), 1713–1719. https://doi.org/10.1038/ki.1992.245

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free